Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Bergmann

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
The Journal of Clinical Investigation|January 29, 2020
TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosisClara Dees, Sebastian Pötter, Yun Zhang, et al.
Nature Communications|December 9, 2021
Author Correction: Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosisDebomita Chakraborty, Barbora Šumová, Tatjana Mallano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune CellsAlexandru-Emil Matei, Markéta Kubánková, Liyan Xu, et al.
Nature Communications|October 26, 2017
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosisDebomita Chakraborty, Barbora Šumová, Tatjana Mallano, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysisGonçalo Boleto, Corrado Campochiaro, Oliver Distler, et al.
Rheumatology (Oxford, England)|November 1, 2024
Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosisShiri Keret, Lisa Kaly, George Schett, et al.
Journal of Autoimmunity|January 22, 2026
Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment responseLorenzo Beretta, Chiu Wai Shirley Chan, Georgia-Savina Moysidou, et al.
Annals of the Rheumatic Diseases|May 23, 2025
Spatial multiomics decipher fibroblast-macrophage dynamics in systemic sclerosisZhijian Li, Aleix Rius Rigau, Wenjie Xie, et al.
Annals of the Rheumatic Diseases|June 3, 2020
PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosisYun Zhang, Lichong Shen, Honglin Zhu, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
The Journal of Clinical Investigation|January 29, 2020
TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosisClara Dees, Sebastian Pötter, Yun Zhang, et al.
Nature Communications|December 9, 2021
Author Correction: Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosisDebomita Chakraborty, Barbora Šumová, Tatjana Mallano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune CellsAlexandru-Emil Matei, Markéta Kubánková, Liyan Xu, et al.
Nature Communications|October 26, 2017
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosisDebomita Chakraborty, Barbora Šumová, Tatjana Mallano, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysisGonçalo Boleto, Corrado Campochiaro, Oliver Distler, et al.
Rheumatology (Oxford, England)|November 1, 2024
Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosisShiri Keret, Lisa Kaly, George Schett, et al.
Journal of Autoimmunity|January 22, 2026
Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment responseLorenzo Beretta, Chiu Wai Shirley Chan, Georgia-Savina Moysidou, et al.
Annals of the Rheumatic Diseases|May 23, 2025
Spatial multiomics decipher fibroblast-macrophage dynamics in systemic sclerosisZhijian Li, Aleix Rius Rigau, Wenjie Xie, et al.
Annals of the Rheumatic Diseases|June 3, 2020
PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosisYun Zhang, Lichong Shen, Honglin Zhu, et al.
Pageof 11